The Rottenstein Law Group, which represents clients with claims stemming from the severe side effects of the drug Fosamax, is taking all necessary measures to comply with the latest order of the federal Fosamax MDL court. New York (PRWEB) November 29, 2012 As the United States District Court for the Southern District of New York prepares to wrap up the federal Fosamax multidistrict litigation matter In Re: Fosamax Products Liability Litigation (No. 06 MD 1789), Judge John F. Keenan has issued an order designed to weed out those cases more likely to be dismissed... as they undergo closer scrutiny. Defendant Merck & Co., Inc., manufacturer of the embattled osteoporosis drug, made a third request of the court for a so-called Lone Pine order. Judge Keenan had denied Mercks previous requests, but he granted this one. By order filed November 20, 2012, Judge Keenan is requiring each claimant whose federal lawsuit is part of the Fosamax MDL but who has not alleged that he or she experienced osteonecrosis of the jaw (ONJ) or osteomyellitis (as a result of having taken Fosamax) to produce certain information and documentation to identify specifically the alleged injuries suffered and to substantiate, with expert testimony, to … Continue reading →

Parkinson's patients have been urged not to stop taking their medication after it emerged that a French man won a six figure payout over a drug that turned him into a gay sex and gambling addict. GlaxoSmithKline paid 159,000 pounds to a Parkinson's patient who said the drug Requip turned him into a gay sex and gambling addict Charity Parkinson's UK said that the case of Didier Jambart, who said he suffered side effects after taking the drug Requip in 2003, highlights that impulsive and compulsive behaviour is a side effect of some Parkinson's medications. But the charity warned that patients taking the drug should not stop taking medication if they are worried. Parkinson's UK chief executive Steve Ford: "These drugs can make a huge difference to the lives of many people with Parkinson's and it's important that people aren't scared of taking them. "We certainly wouldn't want anyone to stop taking their medication out of fear that they too may be at risk. We would encourage anyone who is concerned to find out more about what the potential warning signs - such as changes in behaviour or mood - to come to us to find out more." On Wednesday, … Continue reading →

Dallas, TX (PRWEB) November 29, 2012 German drug maker Boehringer Ingelheim announced this month that they are now working to develop an antidote that will slow internal bleeding in emergency situations.* The announcement comes as the latest report from the Judicial Panel on MultiDistrict Litigation on November 14, 2012 shows the number of Pradaxa internal bleeding cases has increased 50% since September 5th.* According to USA Today on August 19, 2012, Pradaxa led all other medications in 2011 with reports of 3,781 side effects and 542 deaths to the FDA. Anyone affected by internal bleeding after taking Pradaxa is urged to speak with a lawyer about their legal options as soon as possible. On October 3, 2012, the Institute for Safe Medicine Practices QuarterWatch (PDF) estimated that prescription drug complaints to the FDA have risen 90% in the past 4 years, and two drugs, Pradaxa and Chantix, are responsible for 37% of that increase. While all anticoagulants can cause internal bleeding, the Journal of Neurosurgery reported doctors concerns on March 6, 2012 that, once Pradaxa causes internal bleeding, there is currently no antidote to stop it. Due to the number of Pradaxa lawsuits filed, a central federal court has been … Continue reading →

Didier Jambart stole his children's toys to fund his gambling addiction after taking the GSK Parkinson's drug Requip (Europe1fr/Dailymotion) A married father from France turned into a gay sex addict who stole from his friends and family after taking a medicine for Parkinson's disease made by pharmaceutical giant GlaxoSmithKline. In a landmark ruling, GSK was ordered to pay damages of 400,000 (160,000) to Didier Jambart, who began taking Requip in 2003. The medication caused severe side effects in Jambart. Over two years, he stole from friends and sold his children's toys to fund his gambling habit. He advertised himself online for gay sex. He also lost 82,000 by placing bets online, a court in Rennes, France heard. Jambart, 52, from Nantes, western France, had been a upstanding member of the community, a husband and a father before he started taking the medication. He cried as the court ruled in his favour, after a lengthy fight to get compensation from GSK. The British company had previously been ordered to pay 117,000, a decision which it had appealed. "It's a great day. It's been a seven-year battle with our limited means for recognition of the fact that GSK lied to us and … Continue reading →

A French man who claimed a Parkinson's drug turned him into a gambling and gay sex addict has been awarded 197,000 euros in damages, the French Press Agency reported. Didier Jambart, 52, of Nantes, France, sued the pharmaceutical giant GlaxoSmithKline in 2011, claiming the drug, Requip, caused him to lose 82,000 euros gambling on the Internet. He said he also became addicted to gay sex and risky sexual encounters. He said he was raped after starting the drug in 2003 and attempted suicide eight times. "It's a great day," Jambart, who was accompanied by his wife during the emotional ruling, told the French Press Agency. "It's been a seven-year battle with our limited means for recognition of the fact that GSK lied to us and shattered our lives." Parkinson's disease destroys neurons deep within the brain that release the "feel-good" neurotransmitter dopamine. Requip belongs to a class of drugs called dopamine agonists that relieve Parkinson's symptoms -- such as shaking, stiffness, slowness and trouble balancing -- by activating dopamine receptors. But the drugs have side effects that, while rare, can be serious. "There are plenty of reports of people developing side effects from Parkinson's drugs, such as hypersexuality, gambling and … Continue reading →